Pharnext S C Ais A Clinical Stagebiopharmaceutical Company Based In Parisfrancefounded In 2007Thecompany Specializes In Developing Therapies For Neurodegenerativediseasesutilizing Its Proprietary Pleotherapya C Drug Discovery Platformthis Innovativeapproach Combines Big Genomics Data And Artificial Intelligenceto Identify Synergistic Drug Combinationsknown As Pleodruga Cwhich Repurposeexisting Medications To Improveefficacy And Minimizedevelopment Risks Pharnext S Key Products Includepxt 00 Aimed At Treating Charcot Marietooth Diseasetype1Aand Pxt864Which Targets Alzheimer S Diseasepxt 00 Has Completed An International Phaseiii Trial With Positiveresults And Is Currently In A Pivotal Studywhilepxt864 Has Shown Encouraging Outcomes In Phaseii Trialsthecompany Collaborates With Partners Liketasly And Thecharcot Marietooth Association To Enhanceits Research And Expand Its Global Reachfocusing On Addressing Theunmet Needs Of Patients With Neurodegenerativeconditions
No conferences found for this company.
| Company Name | Pharnext Sa |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
